Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Removing gut bacteria may play critical role in reducing cancer risk

Bacteria in the gut are essential for the development of intestinal tumors in mice, according to research led by investigators from the Icahn School of Medicine at Mount Sinai. Removing the bacteria may play a critical role in reducing cancer risk, the researchers write, in the March issue of the Journal of Experimental Medicine.

5 Mar 2014

Researchers identify genes that appear to predict tumors that can evade detection by immune system

Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body’s immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.

5 Mar 2014

Research: Microbes living in gut help drive development of intestinal tumors

It is not only genetics that predispose to bowel cancer; microbes living in the gut help drive the development of intestinal tumors, according to new research in mice published in the March issue of The Journal of Experimental Medicine.

4 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

Mailing test results to patient’s home increase colon cancer screening rates by 40%

Colon cancer screening rates increased by nearly 40 percent when free stool tests were mailed to patients' homes, according to results of a pilot study published today in the journal BMC Cancer.

27 Feb 2014

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO).

26 Feb 2014

Biothera’s Phase 2b clinical trial in NSCLC presented at International Association for the Study of Lung Cancer

Biothera presented results of its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) this past weekend to top clinicians and scientists at the invitation-only International Association for the Study of Lung Cancer meeting on targeted therapies in Santa Monica, CA.

26 Feb 2014

Experts offer eight ways to help prevent colorectal cancer

Colorectal cancer does not always manifest in symptoms, which may include blood in or on the stool, constant stomach pains, and unexplainable weight loss. "Colon cancer is common in both men and women.

25 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.

20 Feb 2014

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.

19 Feb 2014

Pathway Genomics announces launch of Hereditary Colorectal Cancer DNA Insight genetic test

Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.

18 Feb 2014

Findings underscore need to increase access to new treatments for minority groups, older patients

While new and better treatments have improved the odds of survival for patients diagnosed late stage colorectal cancer, that progress has been largely confined to non-Hispanic whites and Asians and those under age 65, according to a new study. American Cancer Society researchers led by Helmneh Sineshaw, M.D., MPH, find there have been no significant increases in survival rates for Hispanics and non-Hispanic blacks with metastatic colon cancer.

16 Feb 2014

Researchers recommend FIT as screening tool for colorectal cancer

Tests that require patients to collect a single stool sample at home and then send it to a lab for analysis will detect about 79 percent of colorectal cancers, according to a new evidence review published in the Annals of Internal Medicine.

4 Feb 2014

Personalized messages over phone can help catch cancer at earliest stages

Although the field of science keeps advancing, it may be the simple telephone that helps save more lives. Anita Kinney, Professor of Medicine and Associate Director for Population Sciences at the University of New Mexico Cancer Center, and her fellow researchers have found that personalized messages over the phone can better help promote preventive measures against cancer.

4 Feb 2014

AVEO Oncology, Astellas Pharma decide to discontinue BATON breast cancer clinical trial

AVEO Oncology today announced that AVEO and Astellas Pharma Inc. have jointly decided to discontinue the BATON (Biomarker Assessment of Tivozanib in ONcology) breast cancer clinical trial, a Phase 2 study in patients with locally recurrent or metastatic triple negative breast cancer (TNBC), due to insufficient enrollment.

30 Jan 2014

Viewpoints: High court weighs home health care workers' union rights; abortion protections becoming 'all but meaningless'

On Tuesday, the justices were presented with a golden opportunity to further increase inequality. The court heard arguments in Harris v. Quinn, a case testing whether home-care providers who work under a union contract with the state of Illinois can avoid paying dues that support the union's collective-bargaining work.

23 Jan 2014

Longer withdrawal times during colonoscopy correlates with higher rate of polyp detection

Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) researchers found that longer withdrawal times during a colonoscopy correlates with a higher rate of polyp detection. The study was recently published online in in the American Journal of Gastroenterology.

22 Jan 2014

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

The Damon Runyon Cancer Research Foundation announced that six scientists with novel approaches to fighting cancer have been named 2014 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer.

21 Jan 2014

Surgeon general: Smoking linked to more than 30 diseases, conditions

The report, which finds that smoking causes even more physical and financial damage than previously estimated, was released 50 years after the first report tied cigarettes to diseases.

20 Jan 2014

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Removing gut bacteria may play critical role in reducing cancer risk

Researchers identify genes that appear to predict tumors that can evade detection by immune system

Research: Microbes living in gut help drive development of intestinal tumors

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Mailing test results to patient’s home increase colon cancer screening rates by 40%

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

Biothera’s Phase 2b clinical trial in NSCLC presented at International Association for the Study of Lung Cancer

Experts offer eight ways to help prevent colorectal cancer

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

iCAD total revenue for Q4 2013 increases 16.8% to $9.1 million

Pathway Genomics announces launch of Hereditary Colorectal Cancer DNA Insight genetic test

Findings underscore need to increase access to new treatments for minority groups, older patients

Researchers recommend FIT as screening tool for colorectal cancer

Personalized messages over phone can help catch cancer at earliest stages

AVEO Oncology, Astellas Pharma decide to discontinue BATON breast cancer clinical trial

Viewpoints: High court weighs home health care workers' union rights; abortion protections becoming 'all but meaningless'

Longer withdrawal times during colonoscopy correlates with higher rate of polyp detection

Damon Runyon Cancer Research Foundation awards $2.25M to six innovative young scientists

Surgeon general: Smoking linked to more than 30 diseases, conditions

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in